FEATURED COMPANIES
- 3M
- B. Braun Melsungen Ag
- Convatec Group Plc
- Essity
- Misonix Inc.
- Smith & Nephew Plc
The global advanced wound management products market should reach $16.0 billion by 2026 from $11.9 billion in 2021 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2021 to 2026.
The advanced nonbiological wound dressings segment of the global advanced wound management products market is expected to grow from $4.7 billion in 2021 to $5.7 billion in 2026 at a CAGR of 4.1% for the forecast period of 2021 to 2026.
The wound biologics/bioactives segment of the global advanced wound management products market is expected to grow from $2.3 billion in 2021 to $4.2 billion in 2026 at a CAGR of 12.2% for the forecast period of 2021 to 2026.
Report Scope:
This report aims to provide a comprehensive study of the global market for AWM products and technologies. It describes the different types of AWM products (advanced nonbiological wound dressings, wound biologics/bioactive, external wound healing devices, anti-adhesion products and other advanced consumable technologies and wound closure sealants and glues) and their current and historical market revenues. Advanced nonbiological wound dressings are categorized in foam, hydrogel, film, alginate and gelling fiber, hydrocolloid, superabsorbent, contact layer, and other advanced nonbiological wound dressings. Wound biologics/bioactive are divided into cellular and tissue-based products (CTPs)/skin substitutes and other biologic therapies.
External wound healing devices are segmented into negative pressure wound therapy systems, oxygen therapy devices and other external wound healing devices. The market for anti-adhesion products and other advanced consumable technologies is divided into anti-adhesion products and advanced debriding and cleansing agents.
This report also studies applications for advanced wound management products: acute wounds and chronic wounds. The AWM market for acute wounds includes surgical and traumatic wounds and burns. The AWM market for chronic wounds includes diabetic foot ulcers, pressure ulcers, and venous leg and other ulcers. An in-depth analysis of the global AWM market includes historical data and market projection on sales by product type, application, end user and region.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors and their respective market shares. However, this report does not cover support /complementary products that are used to enhance wound healing outcomes, such as compression systems, skin protectants, cover dressings, tapes and wound assessment tools.
The Report Includes:
- 31 data tables and 46 additional tables
- An updated review of the global market for advanced wound management (AWM) products and technologies
- Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of key market dynamics (DROs) for advanced wound management products, regulatory scenario, and impact analysis of COVID-19 crisis on the growth of this market
- Estimation of the current market size and revenue forecast for AWM markets, and corresponding market share analysis by product type, end-use, application and geographic region
- Discussion of market trends and industry structure with relate to advanced wound management, applications and business considerations of AWM products and technologies, and descriptions of relevant market forces
- Insight into the recent industry strategies, M&A deals of the major players operating within the global market; their key competitive landscape and company share analysis
- Review of selected new AWM products in development and emerging technologies, clinical trial applications, and potential markets for future developments
- Descriptive company profiles of the major market participants, including 3M, AbbVie Inc., Cardinal Health, Integra LifeSciences, Smith & Nephew PLC and Urgo Group
What is the estimated value of the Global Markets for Advanced Wound Management Technologies?
What is the growth rate of the Global Markets for Advanced Wound Management Technologies?
What is the forecasted size of the Global Markets for Advanced Wound Management Technologies?
Who are the key companies in the Global Markets for Advanced Wound Management Technologies?
FEATURED COMPANIES
- 3M
- B. Braun Melsungen Ag
- Convatec Group Plc
- Essity
- Misonix Inc.
- Smith & Nephew Plc
LOADING...
FEATURED COMPANIES
- 3M
- B. Braun Melsungen Ag
- Convatec Group Plc
- Essity
- Misonix Inc.
- Smith & Nephew Plc
It is estimated that nearly 50 million people suffer from hard-to-heal wounds, globally, including nearly 8.4 million people in the U.S.Wound treatment is complex and varies across a broad continuum of care. Non-healing wounds significantly deteriorate the patients’ quality of life and can cause serious medical events such as limb amputations or premature death. There are two types of wound management technologies: traditional and advanced. A significant percentage of hard-to-heal wounds often requires solutions such as advanced dressings, wound bioactive/biologics and other advanced wound care products. Advanced wound management (AWM) products provide optimal conditions for the natural reparative processes of the wound. These products are favorable to healthcare providers and patients alike, as they promise shorter treatment times and higher cost savings. AWM products are used for the treatment of acute wounds, caused by burns, trauma and surgery; chronic wounds, including diabetic foot ulcers and venous leg ulcers; and prevention of pressure ulcers.
AWM is a significant and growing market. The incidence, chronicity and complexity of wounds is strongly influenced by age and lifestyle factors, including smoking, weight, alcohol consumption, a lack of exercise and an unhealthy diet. Demographic health trends such as an aging population, and the sharp rise in the incidence of diabetes, obesity and other chronic diseases, are resulting in the increased prevalence of systemic comorbidities, leading to the growing prevalence of hard-to-heal wounds. Moreover, a large middle class accessing higher levels of care, and increasing understanding of the economic benefits of using AWS products early in the wound-healing process, are also fueling the growth of the market.
Due to the huge costs associated with delayed wound healing, a growing number of patients worldwide are receiving advanced treatment of wounds. The adoption of AWM products is expected to continue growing at a rapid rate due to increasing awareness of the clinical and economic benefits of using these products among healthcare professionals as well as the growing number of patients demanding more effective treatment solutions. However, the high cost of AWS products, inadequate reimbursement and pricing pressures are the key restraining factors in the market.
The competition in the AWM market is intense and the market is witnessing rapid advances in technologies and an increasing emphasis on intellectual property.
- 3M
- Abbvie Inc.
- Advanced Medical Solutions Group Plc
- Amniox Medical Inc.
- B. Braun Melsungen Ag
- Cardinal Health
- Coloplast A/S
- Convatec Group Plc
- Cook Biotech Inc.
- Dermarite Industries Llc
- Essity
- Integra Lifesciences Holdings Corp.
- Medline Industries
- Mimedx
- Misonix Inc.
- Molnlycke Health Care Ab.
- Organogenesis Holdings Inc.
- Paul Hartmann Ag
- Smith & Nephew Plc
- Urgo Group
- Winner Medical Co., Ltd.
